296 related articles for article (PubMed ID: 7102898)
1. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
Hendrickson M; Ross J; Eifel P; Martinez A; Kempson R
Am J Surg Pathol; 1982 Mar; 6(2):93-108. PubMed ID: 7102898
[TBL] [Abstract][Full Text] [Related]
2. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
Carcangiu ML; Chambers JT
Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract][Full Text] [Related]
4. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.
Sherman ME; Bitterman P; Rosenshein NB; Delgado G; Kurman RJ
Am J Surg Pathol; 1992 Jun; 16(6):600-10. PubMed ID: 1599038
[TBL] [Abstract][Full Text] [Related]
5. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
Sun X; Shi S; Sheng X
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
[TBL] [Abstract][Full Text] [Related]
6. Virulence of papillary endometrial carcinoma.
O'Hanlan KA; Levine PA; Harbatkin D; Feiner C; Goldberg GL; Jones JG; Rodriguez-Rodriguez L
Gynecol Oncol; 1990 Apr; 37(1):112-9. PubMed ID: 2323606
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy].
Xue DB; Ding LJ; Xia AL; Chen D; Xia HP; Teng XD; Xu ST; Zhang SJ; Ren XC
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):671-4. PubMed ID: 21176532
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography of uterine papillary serous carcinoma.
Hamlin DJ; Wilkinson EJ; Morgan LS; Burgener FA; Weaver JW
Comput Radiol; 1984; 8(2):79-83. PubMed ID: 6723276
[TBL] [Abstract][Full Text] [Related]
10. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
Greggi S; Mangili G; Scaffa C; Scala F; Losito S; Iodice F; Pisano C; Montoli S; Viganò R; Pirozzi G; Giannarelli D
Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
[TBL] [Abstract][Full Text] [Related]
11. The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC), age, FIGO grade and nuclear grade.
Rosenberg P; Risberg B; Askmalm L; Simonsen E
Acta Obstet Gynecol Scand; 1989; 68(2):157-63. PubMed ID: 2589042
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic dilemmas in the management of uterine papillary serous carcinoma.
Lackman FD; Craighead PS
Curr Treat Options Oncol; 2003 Apr; 4(2):99-104. PubMed ID: 12594935
[TBL] [Abstract][Full Text] [Related]
13. Uterine papillary serous cancer: a review of the literature.
del Carmen MG; Birrer M; Schorge JO
Gynecol Oncol; 2012 Dec; 127(3):651-61. PubMed ID: 23000148
[TBL] [Abstract][Full Text] [Related]
14. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).
Fader AN; Starks D; Gehrig PA; Secord AA; Frasure HE; O'Malley DM; Tuller ER; Rose PG; Havrilesky LJ; Moore KN; Huh WK; Axtell AE; Kelley JL; Zanotti KM;
Gynecol Oncol; 2009 Nov; 115(2):244-8. PubMed ID: 19712966
[TBL] [Abstract][Full Text] [Related]
15. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
Liang SX; Chambers SK; Cheng L; Zhang S; Zhou Y; Zheng W
Int J Surg Pathol; 2004 Oct; 12(4):319-31. PubMed ID: 15494858
[TBL] [Abstract][Full Text] [Related]
16. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].
Ren YL; Wang HY; Shen L; Yang WT
Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):817-21. PubMed ID: 17327111
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons.
Eifel PJ; Ross J; Hendrickson M; Cox RS; Kempson R; Martinez A
Cancer; 1983 Sep; 52(6):1026-31. PubMed ID: 6883271
[TBL] [Abstract][Full Text] [Related]
19. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
20. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
